Recent studies have identified that METTL14/m6A-mediated epitranscriptomic alterations disrupt ADRB signaling in adipose tissue, contributing to the development of obesity, NAFLD and other metabolic disorders (Kang et al., 2023). This evidence concerns the gene METTL14 and Other metabolic disease.